Abstract
Aminopeptidase N (APN/CD13), a Zn2+-dependent ectopeptidase, is localized on the cell surface and functions as a transmembrane protein. Increased expression and activity of APN have been postulated to correlate with the aggressive behavior of several tumor types. In this study, the osteosarcoma cell line MNNG/HOS was stably transfected with an expression vector capable of expressing the antisense transcript of APN. Four stably transfected clones, the control clones and parental cells were characterized. Stable integration of the antisense vector was confirmed by PCR analysis of genomic DNA. Competitive RT-PCR revealed that mRNA expression of antisense-transfectants was decreased to approximately 37% of the control cell line. The activity assay showed that the enzymatic activity of APN was inhibited to approximately 51% of the control cell line. Antisense-transfection had no influence on the cellular proliferation measured by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, on the motility in Transwell chambers, and on the adhesive potential to collagen I. However, an in vitro invasion assay revealed a significant decrease in the number of cells that migrated through a reconstituted membrane (51% of the control cell line). The adhesive potential to Matrigel was also affected (73% of the control cell line). Furthermore, under in vivo conditions, a reduced potency to metastasize to the lung was shown in an experimental metastasis assay in nude mice. These findings demonstrate that APN plays an active role in the cellular attachment and proteolytic degradation of the extracellular matrix in the metastatic process of osteosarcomas.
Abbreviation: GAPDH – glyceraldehyde-3-phosphate dehydrogenase
Article PDF
Similar content being viewed by others
References
Nicolson GL. Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis. Cancer Matastasis Rev 1993; 12: 324–43.
Liotta LA, Tryggvason K, Garbisa S et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 284: 67–8.
Liotta LA, Goldfarb RH, Brundage R et al. Effect of plasminogen activator (Urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res 1981; 41: 4629–36.
Sloane BF, Honn KV, Sadler JG et al. Cathepsin B activity in B16 melanoma cells: A possible marker for metastatic potential. Cancer Res 1982; 42: 980–6.
Saiki I, Murata J, Watanabe K et al. Inhibition of tumor cell invasion by ubenimex (bestatin) in vitro. Jpn J Cancer Res 1989; 80: 873–8.
Sanderink GJ, Artur Y, Siest G. Human aminopeptidases: A review of the literature. J Clin Chem Clin Biochem 1988; 26: 795–807.
Look AT, Ashmun RA, Shapiro LH et al. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J Clin Invest 1989; 83: 1299–307.
Solhonne B, Gros C, Pollard H et al. Major localization of aminopeptidase M in rat brain. Neuroscience 1987; 22: 225–32.
Turner AJ, Hooper NM, Kenny AJ. Metabolism of neutropeptides. In Kenny AJ and Turner AJ (eds): Mammalian Ectoenzymes. New York: Elesevier Scientific Publishing 1984; 211–42.
Ward PE, Benter IF, Dick L et al. Metabolism of vasoactive peptides by plasma and purified renal aminopeptidase M. Biochem Pharmacol 1990; 40: 1725–32.
Falk K, Rotzschke O, S tevanovic S et al. Pool sequencing of natural HLA-DR,-DQ, and-DP ligands reveals detailed peptide motifs, constraints of processing, and general rules. Immnogenetics 1994; 39: 230–42.
Koch AE, Burrows JC, Skoutelis A et al. Monoclonal antibodies detect monocyte/macrophage activation and differentiation antigens and identify functionally distinct subpopulations of human rheumatoid synovial tissue macropharges. Am J Pathol 1991; 138: 165–3.
Amoscato AA, Alexander JW, Babcock GF. Surface aminopeptidase activity of human lymphocytes. I. Biochemical and biologic properties of intact cells. J Immunol 1989; 142: 1245–52.
Yeager C, Ashmun RA, Williams RK et al. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 1992; 357: 420–2.
Lendeckel U, Kahne T, Arndt M et al. Inhibition of alanyl aminopeptidase induces MAP-kinase p43/ERK2 in the human T cell line KARPAS-2 99. Biochem Biophys Res Commun 1998; 9: 5–9.
Saiki I, Fujii H, Yoneda J et al. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer 1993; 54: 137–43.
Menrad A, Speicher D, Wacker J et al. Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells. Cancer Res 1993; 53: 1450–5.
Fujii H, Nakajima M, Saiki I et al. Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD 13.Clin Exp Metastasis 1995; 13: 337–44.
Kido A, Krueger S, Haeckel C et al. Possible contribution of aminopeptidase N (APN/CD13) to invasive potential enhanced by interleukin-6 and soluble interleukin-6 receptor in human osteosarcoma cell lines. Clin Exp Metastasis 1999; 17: 857–63.
Mechtersheimer G, Moller P. Expression of aminopeptidase N (CD13) in mesenchymal tumors. Am J Pathol 1990; 137: 1215–22.
Kehlen A, Gohring B, Langner J et al. Regulation of the expression of aminopeptidase A, aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 in renal carcinoma cells and renal tubular epitherial cells by cytokines and cAMP-increaing mediators. Clin Exp Immunol 1998; 111: 435–41.
Soderberg C, Giugni TD, Zaia JA et al. CD13 (human aminopeptidase N) mediates human cytomegalovirus infection. J Virol 1993; 67: 6576–85.
Turner AJ.Membrane alanyl aminopeptidase. In Barrett AJ, Rawlings ND and Woessner JF (eds): Handbook of Proteolytic Enzymes. San Diego, California: Academic Press 1998; 996–1000.
Helene C, Toulme JJ. Specific regulation by antisense, sense and antigene nucleic acids. Biochim Biophys Acta 1990; 1049: 99–125.
Ino K, Goto S, Okamoto T et al. Expression of aminopeptidase N on human choriocarcinoma cells and cell growth suppression by inhibition of aminopeptidase N activity. Jpn J Cancer Res 1994; 85: 923–33.
Murata M, Kubota Y, Tanaka T et al. Effect of ubenimex on the proliferation and differentiation of U937 human histiocytic lymphoma cells Leukemia 1994; 8: 2188–93.
Lohn M, Mueller C, Thiele K et al. Aminopeptidase N-mediated signal transduction and inhibition of human myeloid cells. Adv ExpMed Biol 1997; 421: 85–91.
Ota K, Kurita S, Yamada K et al. Immunotherapy with bestatin for acute nonlymphocytic leukemia in adults. Cancer Immunolo Immunother 1986; 23: 5–10.
Sekine K, Fujii H, Abe F. Induction of apoptosis by bestatin (ubenimex) in human leukemic cell lines. Leukemia 1999; 13: 729–34.
Xu Y, Lai LT, Gabrilove JL et al. Antitumor activity of actinonin in vitro and in vivo. Clin Cancer Res 1998; 4: 171–6.
Pasqualini R, Koivunen E, Kain R et al. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res 2000; 60: 722–7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kido, A., Krueger, S., Haeckel, C. et al. Inhibitory effect of antisense aminopeptidase N (APN/CD13) cDNA transfection on the invasive potential of osteosarcoma cells. Clin Exp Metastasis 20, 585–592 (2003). https://doi.org/10.1023/A:1027383729767
Issue Date:
DOI: https://doi.org/10.1023/A:1027383729767